Menu Search
Equities

Osteopore Ltd

OSX:ASX

Osteopore Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.037
  • Today's Change-0.003 / -7.50%
  • Shares traded397.74k
  • 1 Year change-70.65%
  • Beta1.5430
Data delayed at least 20 minutes, as of Nov 15 2024 04:48 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Osteopore Ltd had net income fall 16.13% from a loss of 4.20m to a larger loss of 4.87m despite a 31.02% increase in revenues from 1.69m to 2.22m. An increase in the cost of goods sold as a percentage of sales from 24.76% to 26.22% was a component in the falling net income despite rising revenues.
Gross margin83.51%
Net profit margin-130.20%
Operating margin-121.65%
Return on assets-73.93%
Return on equity-172.56%
Return on investment-172.14%
More ▼

Cash flow in AUDView more

In 2023, cash reserves at Osteopore Ltd fell by 219.42k. Cash Flow from Financing totalled 3.58m or 161.41% of revenues. In addition the company used 3.74m for operations while cash used for investing totalled 7.37k.
Cash flow per share-0.0359
Price/Cash flow per share--
Book value per share0.0157
Tangible book value per share0.0104
More ▼

Balance sheet in AUDView more

Osteopore Ltd has a Debt to Total Capital ratio of 37.68%, a higher figure than the previous year's 0.19%.
Current ratio1.36
Quick ratio1.25
Total debt/total equity0.6047
Total debt/total capital0.3768
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.